Trials / Sponsors / Parion Sciences

Parion Sciences

Industry · 9 registered clinical trials.

Status	Trial	Phase	Started
Completed	Clearing Lungs With ENaC Inhibition in Primary Ciliary Dyskinesia Primary Ciliary Dyskinesia	Phase 2	2016-08-01
Terminated	Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Ey Dry Eye Disease	Phase 2	2016-07-01
Terminated	Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Dry Eye Disease	Phase 2	2016-07-01
Completed	A Study to Evaluate the Safety and Efficacy of VX-371 in Subjects With Cystic Fibrosis Who Are Homozygous for Cystic Fibrosis	Phase 2	2016-02-01
Completed	Clearing Lungs With Epithelial Sodium Channel (ENaC) Inhibition in Cystic Fibrosis (CF) Cystic Fibrosis	Phase 2	2015-04-01
Completed	Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease Dry Eye Disease	Phase 1	2014-07-01
Completed	An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal Wetness Xerostomia, Sjogren's Syndrome	Phase 1 / Phase 2	2010-11-01
Completed	A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome Dry Mouth Associated With Sjogren's Syndrome, Xerostomia	Phase 2	2009-02-01
Completed	Safety Study of Inhaled 552-02 in Cystic Fibrosis Patients Cystic Fibrosis	Phase 1 / Phase 2	2006-01-01